Analogues of hepcidin mimetics with improved in vivo half lives
US11472842B2 · kind B2 · utility
4Cited by
41References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 1, 2020 |
| Grant date | Oct 18, 2022 |
| Priority date | — |
| Expiry date | Oct 1, 2040 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides hepcidin analogues with improved in vivo half lives, and related pharmaceutical compositions and methods of use thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.